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Abstract 
Polysubstance users face a number of severe outcomes in comparison to single-substance users. 
In line with negative reinforcement theory, it has been postulated that polysubstance use occurs 
as a result of the desire to avoid unwanted effects that come from using either a stimulant or 
depressant alone. The current study examined a proxy for negative reinforcement behavior, 
distress tolerance (DT), among single-substance and depressant-stimulant polysubstance users. 
DT is defined as the ability to persist in a goal-directed behavior while experiencing 
psychological distress. Polysubstance users were hypothesized to have lower DT compared to 
those who used only one substance. One hundred seventy six (n = 176) participants were 
recruited through a residential treatment center, where they completed a battery of self-report 
measures and a distress tolerance task. Results from a logistic regression showed that individuals 
with low DT were 2.4 times more likely to be a polysubstance user compared to those with high 
DT. These results suggest depressant-stimulant polysubstance users have a lower ability to 
tolerate psychological distress in comparison to single-substance users. This is the first study to 
examine distress tolerance and polysubstance use, and results may have important clinical 
implications in the treatment of addiction.  
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Polysubstance Use Associated with Lower Distress Tolerance Compared to Single-Substance 
Use 
Background on Polysubstance Use 
Polysubstance users are at a high risk for many negative outcomes. Mixing drugs may 
produce unique, more detrimental effects compared to using one drug alone (Leri, Bruneau & 
Stewart, 2003). Polysubstance users have a higher rate of both non-fatal and fatal drug overdose 
compared to single-drug users (Coffin et al, 2003), and 58.8% of illicit drug-related emergency 
room visits involve two or more drugs (SAMHSA, 2012). Polysubstance users are also more 
likely to engage in injection drug use, be incarcerated, and attempt suicide (Martinotti, Tedeschi, 
Giannantonio, Roy, Janiri & Sarchiapone, 2009; SAMHSA, 2012; Trenz, Scherer, Harrell, Zur, 
Sinha & Latimer, 2012). These findings indicate a more severe clinical profile in comparison to 
single-drug use.   
Polysubstance use has been conceptualized varyingly throughout the literature. While 
some studies have defined it as using more than one drug (Branson, et al., 2012; Florsheim et al., 
2007; Oakland & McChargue, 2014), others use three or more drugs as the criteria (Trenz, 
Scherer, Harrell, Zur, Sinha & Latimer, 2012). In addition, some studies refer to polysubstance 
use as meeting dependence criteria for one drug while also using another (Bierut, Strickland, 
Thompson, Afful & Cottler, 2008; Combs, Soares, O’Connell & D’Angelo, 2004), while others 
use the term to mean any use of multiple drugs in a given period of time (Moss, Chen & Yi, 
2014). There are currently no diagnostic criteria in the Diagnostic and Statistical Manual Fifth 
Edition (DSM-V) for polysubstance abuse or dependence, as it was removed due to an effort to 
focus on individuals’ drugs of choice (American Psychological Association, 2013). In the current 
study, polysubstance use is defined as having reported at least biweekly use of two or more drugs 
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in a 12-month period. Using this definition allows us to include more drug users than using 
criteria of three or more drugs, and also prevents potential bias that may come from only 
examining individuals who meet criteria for dependence.  
In addition to the varying definitions of polysubstance use in the literature, there are 
multiple theories behind polysubstance use. One theory suggests substance users combine drugs 
in order to produce a “synergistic” effect, such that multiple drugs produce a better high than one 
alone. In addition, using one drug may lower individual’s inhibitions and prompt initiation of 
other drugs, resulting in polysubstance use (Leri, Bruneau, & Stewart, 2003).  In the current 
study, we will examine a particular pattern of polysubstance use involving the combination of 
stimulants and depressants, and the role distress tolerance (DT) may play in potentiating this 
pattern of use. In this introduction, we will first discuss how the negative reinforcement model 
can be applied to this pattern of stimulant-depressant polysubstance use. We will then discuss 
how distress tolerance will be used as a measure of negative reinforcement behavior, and 
specifically how low DT may be implicated in polysubstance users. 
Negative Reinforcement Model 
Classical Theory 
 In order to understand the mechanisms underlying polysubstance use, it is helpful to 
examine the theory behind substance use in general. One classical theory of addiction is the 
negative reinforcement model. This model originally proposed that individuals use drugs in order 
to escape withdrawal symptoms, and the relief of these symptoms reinforces the drug use 
behavior (Wikler, 1948). More recent analyses of negative reinforcement conclude there is more 
to the theory than simply aversion to physical withdrawal. Baker et al (2004) proposes that 
negative affect, a universal symptom of withdrawal, mounts when drug levels fall in the body. 
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The feelings enter individuals’ consciousness, causing an increase of “hot processing” and 
decrease in cognitive control, and eventually leads to renewed drug use.  Drug use becomes more 
incentivized due to increasing levels of negative affect and the desire to get rid of this negative 
internal state. Along with this model, Koob and Le Moal (1997) proposed drug addiction may 
result from and potentiate “spiraling distress”, a consistent failure in self-regulation leading to 
negative affect and distress. The authors propose that drug use returns individuals to homeostasis 
through alleviating this negative state, thereby returning the body to a state of equilibrium.  
Taken together, these theories suggest drugs are used to relieve negative internal states, which in 
turn reinforces the pattern of use. In the current study, we seek to examine negative 
reinforcement behavior in polysubstance use.  
Literature on Polysubstance Use  
Although not directly linked in the literature, much of the existing data and theory on 
polysubstance use supports the negative reinforcement model. A consistent finding among 
studies examining patterns of polysubstance use is that individuals intentionally pair drugs based 
on their differing effects on the body. Subsequent drugs may be used to counterbalance and 
alleviate negative, unwanted effects of a first drug.  For example, primary cocaine users may use 
heroin to ease the “over-excitability” caused by cocaine, whereas primary heroin users may use 
cocaine to stay awake or to ease the effects of opioid withdrawal (Leri, Bruneau & Stewart, 
2003).  This phenomenon can be seen through simultaneous use, where the drugs are used at 
once together, or concurrent polydrug use. A combination of drugs can be taken together so that 
the effects are immediately counterbalanced, or a pattern of separate co-use may develop due to 
the chronic nature of addiction (Boys, Marsden & Strang, 2001; Ives & Ghelani, 2006). For 
example, MDMA and cannabis may be used simultaneously in specific club settings to 
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counteract one another, whereas a chronic heroin user may concurrently use cocaine to 
counteract unpleasant symptoms (Hopper et al, 2006; Leri, Bruneau & Stewart, 2003). On a 
survey examining the functions of different drugs, individuals most commonly reported using 
alcohol in order to “ease after effects” of other drugs such as cocaine (Boys, Marsden and Strang, 
2001). In another study involving qualitative interviews with college students, individuals 
reported strategically choosing combinations of drugs in order to manage one another, such as 
smoking marijuana in order to fall asleep after taking an Adderall pill (Quintero, 2009). These 
findings support the theory that polysubstance users choose to use additional substances in order 
to alleviate potential negative effects of a primary drug of choice. In line with the negative 
reinforcement model, the relief of negative affect may reinforce the use of a subsequent drug. 
Functional Uses of Stimulants and Depressants 
Based off this literature examining specific drug pairings, the current study will examine 
the combination of stimulants and depressants in polysubstance use. As seen in the cited studies, 
these two drug classes have opposing effects that lend themselves to be used in combination. 
Depressants are substances that slow the central nervous system, producing a drowsy or relaxing 
effect (National Institute of Drug Abuse, 2014a). Alcohol, a depressant, is often reported to be 
abused because its calming effects, elicited through increasing levels of gamaaminobutyric acid 
(GABA) in the body. Moderate drinkers report motives for drinking such as to enhance or be 
more relaxed in social situations, and heavier drinkers report negative motives such as to feel 
numb or escape negative feelings (Dvorak, Pearsons & Day, 2014; Merril, Wardell & Read, 
2014). In relation to polysubstance use, alcohol is frequently used in conjunction with other 
drugs (Barrett, Darredau, & Pihl, 2006). Users of other depressants such as prescription pills and 
heroin report similar motives of relaxation, as well as pain relief and avoidance of withdrawal 
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(Hartwell et al., 2012; Rigg & Ibañez, 2010; Witteveen, van Ameijden, Prins, & Schippers, 
2007). 
Stimulants, by contrast, elevate blood pressure and heart rate by acting on the brain’s 
monoamine neurotransmitters, increasing alertness and energy levels (NIDA, 2014c). Motives 
for cocaine use are most often reported as to increase energy and to enhance experience 
(Hartwell et al., 2012).  Individuals also report using cocaine and prescription stimulants 
whenever drinking alcohol in order to be mentally clear (Low & Gendaszek, 2002; van der Poel, 
Rodenburk, Dijkstra, Stoele, & van de Mheen, 2009). Motivations for using methamphetamine 
were also reported to increase energy, as well as to lower inhibitions in sexual situations (Kurtz, 
2005). 
Examining the effects of stimulants and depressants demonstrates the two’s opposite 
functions for drug users. Given the current literature on polysubstance use, users may 
deliberately choose certain drug combinations in order to avoid the negative effects of a 
particular drug, and in line with this theory, the most effective combinations would be therefore 
drugs whose effects counterbalance one another. For this reason, the current study will 
specifically look at polysubstance users who combine stimulants and depressants.  
Distress Tolerance and Polysubstance Use 
Given the proposed theory of negative reinforcement as it relates to polysubstance use, 
the current study seeks to examine whether the tendency to engage in negative reinforcement 
behavior is associated with polysubstance use. We will measure negative reinforcement behavior 
with a behavioral measure of distress tolerance. Distress tolerance (DT) is defined as the ability 
to persist in a goal-directed behavior while experiencing a psychological or physical distress 
(Brown, Lejuez, Kahler, Strong, Zvolensky, 2005). Individuals with low distress tolerance 
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consider negative affective states unacceptable and engage in behaviors to quickly relieve them. 
Distress tolerance has been studied among substance users and is associated with an increased 
frequency of substance use (Brandon et al., 2003), as well as poor treatment outcomes, including 
shorter length of abstinence attempts and early treatment drop out (Brown et al, 2009; Daughters 
et al, 2005a; Daughters et al., 2005b.) In addition, distress tolerance moderates the association 
between depressive symptoms and alcohol use, such that individuals with depressive symptoms 
who are low in distress tolerance were more likely to abuse alcohol (Gorka, Ali & Daughters, 
2012). Distress tolerance also serves as a moderator in relationships between personality traits 
and substance abuse, such as those involving impulsivity and trait aggression (Ali et al, 2013; 
Marshall-Berenz, Vujanovic, & MacPherson, 2011; Tull & Gratz, 2013). It is associated with 
coping motives for substance use, suggesting substances are used to escape intolerable negative 
feelings (Simons & Gaher, 2005; Zvolensky et al, 2009). These findings support the use of DT as 
an indicator of negative reinforcement behavior and implicate low DT as a unique risk factor in 
substance abuse and dependence.  
Drawing from the negative reinforcement model, we hypothesize that individuals with 
low distress tolerance may be especially likely to engage in polysubstance use upon experiencing 
any unwanted effects or from their primary drug of choice that induce a negative affective state. 
Individuals who are unable to tolerate such a negative internal state may seek out more 
immediate ways of escaping this distress. Using a drug that counterbalances the unwanted effects 
of the first would alleviate this negative affect, thereby reinforcing this pattern of drug use. A 
study by Kaiser, Millich, Lyman, and Charnigo (2012) found an association between distress 
tolerance and number of illicit drugs tried, which supports this aim. Other than this finding, no 
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studies have examined this relationship using a behavioral measure of distress tolerance or by 
examining certain drug class combinations.   
Risk Factors for Polysubstance Use 
Given the current investigation will test distress tolerance as a potential risk factor for 
polysubstance use, it is lastly important to examine other known risk factors and correlates 
influencing polysubstance use. Polysubstance use is associated with certain personality traits. 
Individuals scored high on impulsivity, aggression, and sensation seeking, and low on 
conscientiousness and aggression (Conway et al., 2003; Hakansson, Schlyter & Berglund, 2011; 
Kelly & Parsons, 2008). It is also is associated with childhood abuse and maltreatment (Armour, 
Shorter, Elahi, Alklit & Christofferson, 2014; Martinotti et al, 2009; Hakansson, Schlyter & 
Berglund, 2011). Early drug use may be an additional risk factor polysubstance use, as earlier 
age of initiation was associated with a higher number of drugs used later in life (Darke, Kaye, & 
Torok, 2012). 
Polysubstance users tend to have a worse clinical profile compared to single-drug or non-
drug users. Polysubstance users have higher rates of Axis I and II disorders in comparison to 
single-substance users (Martinotti et al, 2009; Preti, Prinnas, Ravera & Madeddu, 2010).  This 
population is more likely to suffer from clinical depression, depressive symptoms, suicidal 
ideation, and conduct problems (Daniulaityte, Falk, Wang & Carlson, 2009; Masloawky, 
Schlenberg, O’Malley & Kloska, 2013). In addition, polysubstance use is associated with a 
number of cognitive deficits. A wide range of studies shows lower cognitive abilities in this 
population compared to single drug users, including lower scores on decision making, 
conditional reasoning (Grant, Contoreggi, & London, 2000; Colzato, Hulzinga, & Hommel, 
2009). A study by Kornreich, et al (2012) additionally found impairments in conditional 
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reasoning among polysubstance users compared to controls, scoring lower on both descriptive 
and social contract rules using the Wason selection task. Polysubstance users also performed 
worse than controls on tasks related to working memory, decision-making, and inhibitory control 
(Verdejo-García & Pérez-García, 2006). There is also evidence from studies of the brain to 
support these findings. Polysubstance users showed metabolic abnormalities in the dorsolateral 
prefrontal cortex and lower GABA levels in the anterior cingulate cortex compared to alcoholics 
alone while performing a series of working memory tasks, indicating neural dysfunction and 
deficits in cognition (Abé et al., 2012). Polysubstance users’ prefrontal cortex was also found to 
be smaller in volume compared to controls, implicating possible deficits in executive functioning 
(Liu, Matochik, Cadet & London, 1998). 
These findings demonstrate a number of risk factors and negative outcomes unique to 
polysubstance users in comparison to both single-substance and non-substance using individuals. 
This literature corroborates the current study’s aims to examine distress tolerance as another 
potential risk factor for polysubstance use.  
Current Aims 
The current study will examine the relationship between distress tolerance and 
polysubstance use. Specifically, it is hypothesized that a) polysubstance users will have lower 
distress tolerance compared to single-substance users; and b) polysubstance users who combine 
stimulants and depressants will have lower distress tolerance compared to single drug users or 
stimulant-only and depressant-only polysubstance use combinations. 
 
Method 
Participants 
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This study used data collected as part of a larger randomized control trial, which 
examined the effectiveness of a behavioral activation treatment among substance users. The 
current study originally included 185 participants. Seventeen participants’ data were not included 
due to either having technical difficulties with the distress tolerance task (n = 9) or meeting 
criteria for depressant-only polysubstance use (n = 8; see “Substance Use and Sample 
Exclusions” in Results section for a description of drug use exclusion criteria). The final sample 
included 176 participants. The sample aged from 19 to 72, the average age being 43.56 (SD = 
10.89). The sample was predominantly male (67.6%, n = 119) and African-American (92.0%, n 
= 162). Less than half of participants (46.6%) had a high school education or an equivalent. Fifty 
four percent (n = 95) of participants earned less than 10,000 a year in household income, and 
79.5% (n = 140) were unemployed. The majority of the sample was single (65.3%, n = 115). 
Lastly, 68.8% (n = 121) of participants’ treatment was court-mandated.  
Procedure 
Participants were recruited from a residential treatment center located in Washington 
D.C. All interested individuals were invited for an interview to confirm their eligibility. 
Participants had to be between ages 18-65. Exclusion criteria were based on having limited 
mental competency (scoring <23 on the Mini Mental State Examination), psychosis, or having 
used psychotropic medication for 3 or less months. If eligible, participants were included in the 
study where they completed the assessment during the first week of their treatment. This 
assessment took approximately two and a half hours. Participants first completed a questionnaire 
regarding their demographic information. They then received a diagnostic interview using the 
Structured Clinical Interview for the DSM-IV (SCID; First, Spitzer, Gibbon & Williams, 2012). 
After, they filled out a battery of self-report measures, which included measures relevant to the 
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current proposal, namely a substance use history questionnaire, the Beck Depression Inventory 
(BDI-II; Beck, Steer & Ball, 1996), Beck Anxiety Inventory (BAI; Beck, Epstein, Brown & 
Steer, 1988), and the Eysenck I7 Impulsivity Questionnaire (I7; Eysenck. & Eysenck, 1985). 
They then completed a computerized behavioral distress tolerance task, the Paced Auditory 
Serial Addition Task (PASAT-C; Lejuez, Kahler, & Brown, 2003). Participants received $25 for 
completing the assessment. Participants were then randomized to a treatment condition, however 
all procedures for the current study occurred during the first assessment, prior to randomization.  
Measures 
Demographics and Screening 
Participants provided sociodemographic information on their age, race/ethnicity, 
education level, marital status, employment status, and annual household income.  
The Mini- Mental State Examination (MMSE; Folstein, Folstein & McGufh, 1975) was 
administered to test patients’ mental competency. This is a 30-item measure, scored from 0-30, 
with a score of 24 or less signifying impaired cognitive functioning. It takes 5-10 minutes to 
complete. The MMSE has been validated using a range of populations, including in clinical 
settings. A Use of Medications form was administered, where participants indicated the type, 
frequency, and dose of any medications they used along with the reason for taking it.  
Substance Use 
A standard self-report substance use questionnaire (e.g., Babor, Del Boca, Litten & Allen, 
1992) was used to obtain information on individuals’ drug use history. Participants were asked if 
they ever used a drug in their lifetime, how frequently they used it in the past year, and how 
frequently they were using it during the time in their life when it was most heavily used. They 
answered on a six-point Likert scale ranging from “never”, “one time”, “monthly or less”, “2 to 4 
POLYSUBSTANCE USE ASSOCIATED WITH LOWER DISTRESS TOLERANCE 14 
times a month”, “2 to 3 times a week” and “4 or more times a week”. The questionnaire covered 
11 substances: cannabis, alcohol, cocaine, ecstasy, stimulants, sedatives, opiates, hallucinogens, 
PCP, inhalants, and nicotine. Specifically, the question “About how often did you use [drug 
name] in the past 12 months?” was used to determined drug use status. A cutoff score of ≥3 on 
the Likert scale, indicating at least biweekly use, was used to categorize individuals as users or 
non-users.  
Individuals were only included in the sample if they used at least one stimulant or 
depressant. Cocaine and methamphetamine were categorized as stimulants (NIDA, 2014b), and 
alcohol, opioids, and sedatives were categorized as depressants (NIDA, 2014a; NIDA, 2014c). 
Polysubstance use was defined as meeting criteria for use of two or more drugs. These 
individuals were then divided into three categories: depressants only, defined as having used two 
or more depressants and no stimulants; stimulants only, defined as having used two or more 
stimulants and no depressants; and depressant-stimulant, defined as having used at least one 
stimulant and at least one depressant.  
Distress Tolerance 
 The Computerized Paced Auditory Serial Addition Task (PASAT-C; Lejuez, Kahler, & 
Brown, 2003) is a computerized task designed to measure distress tolerance by eliciting 
psychological distress. In the task, participants are asked to add up a series of numbers on the 
screen that are presented one at a time. They must sum the current number with the previous 
number and enter the answer using a number pad on the screen before the next one appears. 
Participants are told they receive one point for each correct answer, and a loud explosion sounds 
upon an incorrect answer. In the Warm-Up phase, the task begins at a low difficulty with a 3-
second latency between numbers, lasting for three minutes. In the Measurement phase, the 
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latency is titrated based on individuals’ performance. It is then halved in the last minute of the 
phase, becoming extremely difficult. The last level is the Quit phase, where the latency continues 
at this difficulty, eliciting forced failure and distress. Participants are told they can quit at any 
time during this phase. Distress tolerance is measured as quit (low DT) or no quit (high DT).  
During the task, participants are also asked to self-report their level of distress on a 100-point 
Likert scale, with 0 being none and 100 extreme. The ratings occurred during the tasks in 
between level-difficulty changes, providing momentary assessments of anxiety and discomfort 
levels.  
Potential Covariates 
Because polysubstance users were found to have higher rates of Axis I and II disorders in 
comparison to single-substance users (Preti, Prinnas, Ravera & Madeddu, 2010; Martinotti et al, 
2009), comorbid diagnoses were assessed to ensure that any differences between the two groups 
were not due to differences in psychopathology. The Structured Clinical Interview for DSM-IV 
Axis I disorders (SCID-I; First, Spitzer, Gibbon & Williams, 1997) and Axis II disorders (SCID-
II; First, Spritzer, Gibbon, Williams & Benjamin, 1994) were used to assess current 
psychopathology. Both measures have been utilized extensively in clinical research and shows 
good internal consistency across diagnoses (α = .71-.94; Maffei et al, 1997). 
Depression was specifically found to be higher in polysubstance users compared to 
single-substance users (Daniulaityte, Falk, Wang & Carlson, 2009; Masloawky, Schlenberg & 
Kloska, 2013), and thus depressive symptoms were included as a covariate. The Beck 
Depression Inventory (BDI-II; Beck, Steer & Ball, 1996) was used to assess levels of depressive 
symptoms. It is a 21-item, self-report questionnaire that is scored from 0-63. A score of 0-13 
indicates a normal mood, 14-20 as mild depression, 21-30 as moderate depression, and 30-63 as 
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severe depression. The BDI-II has excellent internal consistency in community samples (α =.92; 
Beck, Steer & Ball, 1996) and among substance users (α = .92; Magidson et al, 2013). Anxiety 
symptoms were also found to be higher in polysubstance users compared to single-substance 
users (Oakland & McChargue, 2014) and will be included as a potential covariate. The Beck 
Anxiety Inventory (BAI; Beck, Epstein, Brown & Steer, 1988) was use to assess anxiety 
symptoms Developed after the BDI-II in order to minimize its overlap with depressive 
symptoms, the BAI is also a 21-item self-report questionnaire with scores ranging from 0-62. A 
score of 0-7 indicates a normal mood, 8-15 mild anxiety, 16-25 moderate anxiety, and 26-63 
severe anxiety. The BAI has shown strong internal consistency in community and substance 
using samples (α=.92; Beck, Epstein, Brown & Steer, 1988; α=.91; Steer, 1995).  
In addition, impulsive personality traits were found to be prevalent among polysubstance 
users (Hakansson, Schlyter & Berglund, 2011). To assess impulsivity as a potential covariate, the 
I.7 Impulsiveness Questionnaire (I.7; Eysenck. & Eysenck, 1978) was used. It is a 54-item, self-
report questionnaire in a yes/no format. The scale assesses impulsivity using either a total score 
or among three subscales: impulsiveness, venturesomeness, and empathy. The current study used 
the total score as a measure of impulsivity. The I7 has shown good internal consistency in 
community and substance using samples (α=.82; Hayaki, Anderson & Stein, 2006). 
Analytic Plan 
 After categorizing the sample, we examined the relationship between potential covariates 
and substance use group. Chi-square analyses were used for potential categorical covariates 
(psychiatric disorders and demographic information), and ANOVAs were used for potential 
continuous covariates (depressive and anxiety symptoms, impulsivity, and age). Any variables 
found to be significantly associated with substance use group were included in subsequent 
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analyses. Logistic regression analyses were utilized to examine the unique effect of DT on 
substance use group, with covariates entered in Step 1, and DT entered in Step 2.  
Results 
Substance Use and Sample Exclusions 
In Table 1, the sample was categorized into polysubstance users and single-substance 
users. Because only eight participants met criteria for depressant-only polysubstance use, and 
zero participants for stimulant-only polysubstance use in the original sample, we only used 
depressant-stimulant polysubstance users in our analyses. Overall, 40.3% (n = 71) of the sample 
met criteria for depressant-stimulant polysubstance use. Table 2 indicates frequencies of use of 
each drug in the sample using the cut-off score of ≥3 on the substance use questionnaire. Alcohol 
and cocaine were the most widely used drugs in the sample.   
Identification of Covariates 
Potential covariates were analyzed for their relation with substance use category (single 
or poly) and reported in Tables 3 and 4. Age was significantly related to substance use group, 
such that polysubstance users were older (M = 47.22; SD = 8.62) than single-substance users (M 
= 41.44; SD = 11.75). Neither additional demographic characteristics, psychiatric comorbidities, 
marijuana use, depressive and anxiety symptoms, nor impulsivity were related to substance use 
category.  
Distress Tolerance 
Using participants’ data from the PASAT-C, several relationships were analyzed in order 
to assess overall task performance in the sample. The average persistence time of the task was 
352.11 seconds (SD = 140.04), and 23.3% (n = 41) of participants demonstrated low distress 
tolerance by quitting the task. Individuals experienced a significant increase in distress pre (M = 
POLYSUBSTANCE USE ASSOCIATED WITH LOWER DISTRESS TOLERANCE 18 
25.91, SD = 23.36) to post (M = 31.33; SD = 25.73) task [F(1, 174) = 24.39, p<.001], indicating 
the task was psychologically stressful. Change in reported distress pre to post task was related to 
distress tolerance [F(1, 174) = 3.88,  p = .05], such that participants who showed low DT 
experienced a higher increase in negative mood (M = 9.65; SD = 18.12) compared to those with 
high DT (M =  4.15; SD = 14.85). The number of correct responses during the first two levels of 
the task measured skill (M = 5.49, SD = 3.15).  Skill level was not related to DT [F(1, 175) = 
1.45, p = .231], demonstrating participants’ distress tolerance did not depend on how well they 
performed during the task.  
Distress Tolerance and Polysubstance Use 
As displayed in Table 5, a logistic regression was conducted to examine the hypothesis 
that depressant-stimulant polysubstance users have significantly lower distress tolerance than 
single substance users. Variables that were significantly related to substance use category (i.e., 
age) were entered into Step 1. Distress tolerance was entered in Step 2 to determine its unique 
effect on polysubstance use. Step 1 was significant, where age predicted substance use group 
such that for every one year increase in age, individuals were 5% more likely to be a 
polysubstance user. In Step 2, DT emerged as a significant predictor of substance use group 
above and beyond age, and the complete model remained significant, χ 2(2) = 15.53, p < .001. 
Specifically, those who demonstrated low DT were 2.4 times more likely to be a polysubstance 
user compared to those with high DT (Wald = 5.46, p < .05; OR = 2.40, 95% CI = .1.15-5.01). 
As illustrated in Figure 1, 17.1% of single-substance users compared to 32.4% of polysubstance 
users demonstrated low distress tolerance on the PASAT-C. Given the sample limitations, we 
were not able the address the study’s second aim of examining distress tolerance between 
different categories of polysubstance use.  
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Discussion 
In the current study, data from drug users in a residential treatment center were used to 
examine the relation between polysubstance use and distress tolerance. As predicted, depressant-
stimulant polysubstance users evidenced significantly lower distress tolerance on the PASAT-C 
compared to single substance users, which was significant above and beyond the covariate age. 
The second aim of the study was to examine DT among different groups of polysubstance users. 
However, due to sample limitations, depressant-stimulant polysubstance use was the only 
category that could be formed, and no meaningful analyses could be completed. 
The study’s findings provide support for the hypothesis that polysubstance users have 
decreased tolerance to experiencing psychological distress, and may be likely to engage in 
behaviors (e.g., reinitiating drug use) to alleviate such negative affective states. Given the known 
associations between distress tolerance and relapse behaviors, we specifically used distress 
tolerance in this study as a measure of this negative reinforcement behavior commonly seen in 
addiction (Baker et al., 2004; Wikler, 1948). Based on existing literature that polysubstance users 
use drugs to counteract unwanted effects of a first drug (Boys, Marsden, & Strang, 2001; Leri et 
al., 2001; Quintero, 2009), one potential explanation for polysubstance users’ observed low DT 
could be the inability to tolerate psychological distress resulting from a primary drug of choice. 
In an effort to rid this distress, subsequent drugs may be taken whose effects can alleviate 
negative state (e.g., alcohol to relieve irritability resulting from a cocaine high), which negatively 
reinforces this pattern of use. Single substance users may be less affected by low distress 
tolerance, and may therefore be less affected by any potential negative effects of their drug of 
choice. For example, a single drug user whose drug of choice is cocaine may be able to better 
tolerate potentially negative side effects of cocaine, such as irritability, anxiety, or a 
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“comedown”, better than a polysubstance user who needs additional substances to alleviate this 
distress. While our results support this hypothesis and are in line with qualitative data from drug 
users who report these processes (Quintero, 2009), the findings are merely suggestive, as we did 
not directly examine this theory. 
In regard to the study’s second aim of comparing different polysubstance use groups, the 
lack of individuals in the stimulant-only (n = 0) and depressant-only categories (n = 8) is 
corroborative of the study’s hypothesized theory of polysubstance use. We hypothesized that 
those two groups would have lower DT compared to depressant-stimulant users (n = 76). 
However, the overwhelming majority belonging to the latter category supports the study’s 
proposed theory that polysubstance use centers on the combination of drugs with opposing 
effects. Stimulants’ and depressants’ opposing effects may lend themselves to be used together 
when the effect of one alone causes distress or discomfort.  Based on this theory, we should 
expect polysubstance use involving two or more of the same drug class to be less common 
because it would serve no functional purpose, nor be reflective of negative reinforcement 
behavior because both drugs would provide the same effect. This was indeed the case in the 
current sample. Much of the polysubstance use literature examines depressant-stimulant 
combinations, specifically cocaine and depressant combinations (Brache, Stockwell & 
Macdonald, 2012; Leri & Stewart, 2001; Lightowlers & Sumnall, 2014; Macdonald et al., 2015). 
Specifically, cocaine and alcohol combinations have been found to be especially common among 
polysubstance users and common in treatment populations (Pakula, Macdonald, and Stockwell, 
2009). Despite not addressing our original hypothesis, our sample ultimately was in line with the 
literature in examining common patterns of drug use. In addition, using only depressant-
stimulant users allowed us to examine the theory of negative reinforcement in this pattern of 
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drug use, which we would not be able to do if we had grouped together all polysubstance users in 
comparing them to single-substance users.    
There were several limitations to the study. First, multiple drug classes (marijuana, PCP, 
and ecstasy) were not used for categorization purposes, which may have limited the sample. 
Marijuana is a noteworthy exclusion because of its common use in the population. However, 
because marijuana does not clearly fit into the stimulant or depressant category, it was not used 
as inclusion criteria for stimulant or depressant polysubstance use. There were no significant 
group differences in weekly marijuana use between polysubstance and single-substance users, 
but weekly users who used other substances may have been left out of the polysubstance use 
category. There is consequently the potential that not all polysubstance users were captured in 
our results. In addition, the sample did not allow us to address the study’s second aim of 
comparing distress tolerance across polysubstance use categories. The sample being primary 
depressant-stimulant polysubstance use is consistent with our hypothesis, but without being able 
to compare to other groups, we are not able to make any conclusions on potential differences 
among polysubstance users. Being able to compare these different groups would strengthen the 
study’s conclusion that there is a specific pattern of depressant-stimulant polysubstance use that 
is different from other drug use patterns. A final limitation of the study is the demographic 
characteristics of the sample. The study used primarily middle-aged, low-income, African-
American males from a residential treatment center. This may limit the generalizability of the 
study’s results to all substance users. Specifically, there are bodies of literature on young adult’s 
polysubstance use (Moss, Chen, Chiung, & Yi, 2014; Ray, Pandina, & Bates, 2014; Redonnet, 
Chollet, Fombonne, Bowes & Melchior, 2012) or specific patterns of hallucinogen polysubstance 
use in club settings (Barrett, Gross, Garant & Pihl, 2005; Gouzoulis-Mayfrank & Daumann, 
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2006; Sumnall & Cole, 2005). While our study adds to the polysubstance use body of literature, 
it is important to note that different drug use patterns and outcomes exist depending on the 
sample. Nevertheless, the current sample is generally underrepresented in the literature and 
merits research attention. 
Despite these limitations, a number of implications can be drawn from the current study. 
First, these findings are relevant in the treatment of substance use disorders. Due to the known 
associations between distress tolerance and relapse or drug-seeking behaviors (Brandon et al., 
2003; Brown et al, 2009; Daughters et al, 2005), polysubstance users may be especially likely to 
relapse after receiving treatment and may warrant special clinical attention. Because 
polysubstance use may be the result of a negative reinforcement from specific drug 
combinations, clinicians should seek to understand patient’s specific patterns of drug use. They 
should identify the patient’s specific drugs of choice and the functions of their interaction. This 
could inform how a clinician intervenes with the individual. Psychoeducation could also be used 
to make individuals aware of their pattern of drug use, and that using multiple drugs may be 
serving to regulate their internal states. The American Psychiatric Association (APA) removed 
the diagnosis of polysubstance use disorder in the DSM-5 in an effort to promote clinicians 
having an in-depth understanding of all the patients’ drug of choice (APA, 2013). Polysubstance 
use disorder was used to diagnose individuals whose use of three or more drugs collectively 
impaired them, but no single drug’s use could account for their problems (APA, 1994). Based on 
these potential clinical implications, our findings may be in line with the APA’s new 
recommendations. Polysubstance use should not be thought of as merely an aggregate for the 
number of drugs someone uses; rather, there are specific interactions that could lead to 
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individuals engaging in this pattern. Our findings thus have important clinical implications, as 
identifying the functions of specific drug combinations may be an essential part of treatment.  
Further research should continue the current study’s attempt to theorize patterns of 
polysubstance use. The current literature is consistent in its findings (i.e., that users combine 
stimulants and depressants based on the unwanted effects of one), yet lacks a consistent 
framework and language to make inferences on why this pattern of use occurs, and how these 
individuals are different from other types of substance users. Because we could not compare 
different types of polysubstance use due to sample restrictions, further research should 
additionally explore the frequency and outcomes of polysubstance users who use multiple drugs 
of the same class in comparison to depressant-stimulant users. The latter is the focus of the 
current study but is ultimately only one category of drug use. Lastly, longitudinal research could 
be beneficial in detecting how distress tolerance predicts future polysubstance use. Given the 
very severe outcomes polysubstance users face, further research on understanding the etiology of 
this behavior is warranted. The current study is the first to examine distress tolerance between 
poly- and single-substance users, and provides preliminary evidence that polysubstance users 
have uniquely low distress tolerance.  
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Table 1 
 
Categorized sample by drug use group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
User category n % of sample 
Single substance  105 59.7 
Stimulant-depressant polysubstance  71 40.3 
Total 176 100 
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Table 2 
 
Frequency of drug use in the sample 
 
Substance n % of sample 
Alcohol 130 73.9 
Cocaine 99 56.3 
Marijuana 49 27.8 
PCP 35 19.9 
Opioids 26 14.8 
Ecstasy 4 2.3 
Sedatives 3 1.7 
Methamphetamine 1 0.6 
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Table 3 
 
Relation between potential categorical covariates and substance use group 
  
 
Potential Covariate 
% Single-
substance 
(n = 105) 
% 
Depressant-
Stimulant 
Polysubstance 
(n = 71) 
Statistic 
Demographics    
Gender (% female) 31.4 33.8 χ
 2
(1) = .11, p = .74 
Ethnicity (% African American) 92.4 95.8 χ
 2
(1) = .83, p = .36 
Education (% less than high 
school) 
25.5 24.3 
χ 2(2) = 1.04, p = .60 
Marital Status (% Single) 68.6 60.6 χ 2(1) = 1.20, p = .27 
Psychiatric Comorbidity    
Major Depressive Disorder 24.8 18.3 χ
 2
(1) = 1.02, p = .31 
Bipolar Disorder 5.7 1.4 χ 2(1) = 2.01, p = .16 
PTSD  6.9 12.9 χ 2(1) = 1.77, p = .18 
Psychosis  5.7 7.0 χ
 2
(1) = .13, p = .72 
Generalized Anxiety Disorder 9.8 12.7 χ 2(1) = .35, p = .55 
Panic Disorder 2.9 1.4 χ
 2
(1) = .42, p = .52 
Antisocial Personality Disorder 26.2 36.8 χ 2(1) = 2.16, p = .14 
Borderline Personality Disorder 5.9 12.9 χ
 2
(1) = 2.54, p = .11 
Weekly Marijuana Use 30.5 23.9 χ
 2
(1) = .90, p = .34 
Note: Percentages reflect the proportion of individuals in each group who meet criteria for the 
covariate; PTSD = post-traumatic stress disorder 
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Table 4 
 
Relation between potential continuous covariates and substance use group 
 
 
 
Single-
substance 
M (SD) 
Depressant-
Stimulant 
Polysubstance 
M (SD) 
df F η p 
BDI 
10.47 
(9.64) 
11.32 (10.81) 
Between         1 
Within        170 
.37 .002 .54 
BAI 
9.08 
(12.11) 
8.23 (10.69) 
Between         1 
Within        166 
.22 .001 .64 
Eysenck I7 
9.35 
(4.31) 
9.66 (4.56) 
Between         1 
Within        173 
.20 .001 .66 
Age** 
41.47 
(11.81) 
46.65 (8.55) 
Between         1 
Within        174 
10.08 .055 .002 
Note: BDI = Beck Depression Inventory II; BAI = Beck Anxiety Inventory; Eysenck I7 = I7 
Impulsiveness Questionnaire 
**p < .01 
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Table 5 
 
Binary logistic regression using covariates and distress tolerance to predict substance use group 
 
 
Predictor B SE Wald/ χ 2 Odds Ratio 95% CI 
Step 1** χ 2(1) = 9.98, p = .002 
Age** .05 .02 9.16 1.05 [1.02, 1.08] 
Step 2* χ 2(1) = 5.55, p = .018 
Age** .05 .02 9.31 1.05 [1.02, 1.08] 
Distress Tolerance* .88 .38 5.46 2.40 [1.15, 5.01] 
Note: CI = confidence interval 
*p < .05, **p < .01 
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Figure Captions 
 
Figure 1: Percentages of single-substance and polysubstance users who quit the PASAT-C  
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Figure 1: Percentages of single-substance and polysubstance users who quit the PASAT-C  
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